← FDA ENFORCEMENT
D-0150-2025Class II

Provepharm Inc.

Recalling firm
Provepharm Inc.
Product type
Drug
Status
Ongoing
Report date
2024-12-25
Distribution
Nationwide within the United States
Firm state
PA
Product quantity
2160 packs/5 ampules per pack = 10,800 ampules
Initiated by
Voluntary: Firm initiated
Reason for recall

Discoloration

Product description

Dihydroergotamine Mesylate Injection, solution for injection, USP, 1 mg/mL Ampules, Rx Only, Distributed by: Provepharm Inc. 100 Springhouse Drive Suite 105, Collegeville, PA 19426, NDC 81284-411-05

Code / lot info

Lot #: F9026F01, F9026F02, Exp. Date 12/2025

Data: U.S. FDA openFDA enforcement API. Recall details are as reported by the FDA. The quality-domain mapping and severity are a SPEQ editorial interpretation of the recall reason, not an official FDA classification.